Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Abstract
Highly potent, but poorly water-soluble, drug candidates are common outcomes of contemporary drug discovery programmes and present a number of challenges to drug development - most notably, the issue of reduced systemic exposure after oral administration. However, it is increasingly apparent that formulations containing natural and/or synthetic lipids present a viable means for enhancing the oral bioavailability of some poorly water-soluble, highly lipophilic drugs. This Review details the mechanisms by which lipids and lipidic excipients affect the oral absorption of lipophilic drugs and provides a perspective on the possible future applications of lipid-based delivery systems. Particular emphasis has been placed on the capacity of lipids to enhance drug solubilization in the intestinal milieu, recruit intestinal lymphatic drug transport (and thereby reduce first-pass drug metabolism) and alter enterocyte-based drug transport and disposition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conventional absorption and bioavailability assessments, and the body-weight regressions built upon them, implicitly assume the portal route and seldom quantify the lymphatic contribution, even though, for suitable compounds, it can represent a substantial fraction of systemic exposure [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“This route becomes quantitatively relevant only for compounds that combine high lipophilicity with appreciable long-chain triglyceride solubility, for which a log P greater than 5 and a lipid solubility above approximately 50 mg/g are commonly cited as approximate thresholds [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“Because lymphatic delivery reaches the systemic circulation while bypassing hepatic first-pass metabolism, it can materially increase the oral bioavailability of affected compounds and lower their apparent first-pass loss in a manner that a body-weight regression of systemic clearance or volume cannot anticipate [28,29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“For highly lipophilic drugs, a fraction of the absorbed dose can bypass the portal circulation entirely and reach the systemic circulation via the intestinal lymphatics, associated with triglyceride-rich lipoproteins (chylomicrons) assembled within the enterocyte [28,29].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“The extent of transport is highly sensitive to prandial state and to the type and quantity of co-administered lipid, which differ across preclinical study designs and between the fasted conditions typical of first-in-human protocols and the fed conditions under which lymphatic transport is greatest [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
Citations
Cites
Items 201–253 of 253
PARTITIONING OF POLAR FATTY ACIDS INTO LYMPH AND PORTAL VEIN AFTER INTESTINAL ABSORPTION IN THE RAT
McDonald, G. B., & Weidman, M. (1987) · Quarterly Journal of Experimental Physiology · doi:10.1113/expphysiol.1987.sp003059 · Cited by 48
Apolipoprotein A-IV acts in the brain to inhibit gastric emptying in the rat
Okumura, T., Fukagawa, K., Tso, P., Taylor, I. L., & Pappas, T. N. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.270.1.g49 · Cited by 48
Hydrocarbon transport in chylomicrons and high‐density lipoproteins in rat
Vost, A., & Maclean, N. (1984) · Lipids · doi:10.1007/bf02537404 · Cited by 47
In Vivo Model for Ciclosporin Intestinal Absorption in Lipid Vehicles
Reymond, J.-P., Sucker, H., & Vonderscher, J. (1988) · Pharmaceutical Research · doi:10.1023/a:1015939307478 · Cited by 47
PENTADECANOIC ACID-5-C14: ITS ABSORPTION AND LYMPHATIC TRANSPORT
Chaikoff, I. L., Bloom, B., Stevens, B. P., Reinhardt, W. O., & Dauben, W. G. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56085-3 · Cited by 46
Bile Increases Intestinal Lymphatic Drug Transport in the Fasted Rat
Trevaskis, N. L., Porter, C. J. H., & Charman, W. N. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-6808-9 · Cited by 46 · cited 1×
“Lipids and changes to enterocyte biology The potential for lipids and lipidic excipients to interact with lipid and drug transport pathways into and across the enterocyte has emerged as a growing area of interes”
BackgroundSelf-citationDietary saturated fatty acid content affects lymph lipoproteins: studies in the rat.
FELDMAN, E. B., Russell, B. S., Chen, R., Johnson, J., Forte, T. M., & Clark, S. B. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37911-6 · Cited by 46
The intestine expresses pancreatic triacylglycerol lipase: regulation by dietary lipid
Mahan, J. T., Heda, G. D., Rao, R. H., & Mansbach, C. M. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.6.g1187 · Cited by 46
The transport of organic cations in the small intestine: Current knowledge and emerging concepts
Kim, M. K., & Shim, C. (2006) · Archives of Pharmacal Research · doi:10.1007/bf02969273 · Cited by 44
Uptake and metabolism of circulating fatty acids by rat intestine
Mansbach, C. M., & Dowell, R. F. (1992) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1992.263.6.g927 · Cited by 44
Steady-state kinetic analysis of triacylglycerol delivery into mesenteric lymph
Mansbach, C. M., & Arnold, A. (1986) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1986.251.2.g263 · Cited by 43
Lipid vehicles for intestinal lymphatic drug absorption
Cheema, M. S., Palin, K. J., & Davis, S. S. (1987) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1987.tb07164.x · Cited by 43
THE ROLE OF MICELLAR SOLUBILIZATION IN LIPID ABSORPTION
Simmonds, W. (1972) · Australian Journal of Experimental Biology and Medical Science · doi:10.1038/icb.1972.35 · Cited by 43
Lucangioli, S. E., Kenndler, E., Carlucci, A. M., Tripodi, V. P., Scioscia, S. L., & Carducci, C. N. (2003) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(03)00377-7 · Cited by 41
Acidic mucin layer facilitates micelle dissociation and fatty acid diffusion
Shiau, Y. F., Kelemen, R. J., & Reed, M. A. (1990) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1990.259.4.g671 · Cited by 41
Nankervis, R., Davis, S. S., Day, N. H., & Shaw, P. N. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04265-2 · Cited by 38 · cited 1×
“70 ), fat-soluble vitamins and their derivatives, retinoid”
BackgroundTrevaskis, N. L., Porter, C. J. H., & Charman, W. N. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008102 · Cited by 37 · cited 1×
“A recent study has also suggested that partition into the developing lipoprotein assembly pathways within the enterocyte might result in a reduction in enterocyte-based metabolis”
BackgroundSelf-citationThe role of the lymphatic transport in the enteral absorption of naftifine by the rat
Grimus, R. C., & Schuster, I. (1984) · Xenobiotica · doi:10.3109/00498258409151414 · Cited by 35
Lespine, A., Chanoit, G. P. A., Bousquet‐mélou, A., Lallemand, E. A., Bassissi, F., Alvinerie, M., & Toutain, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.003 · Cited by 35 · cited 1×
“Consistent with these guiding criteria, various highly lipophilic drugs and xenobiotics have been shown to be transported to varying degrees by the intestinal lymph following oral administration, including moxidecti”
BackgroundWhite, D. G., Story, M. J., & Barnwell, S. G. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90221-9 · Cited by 35 · cited 1×
“The pig might also provide an alternative to the dog as a suitable larger animal mode”
BackgroundEffect of Oily Vehicles on Absorption of Mepitiostane by the Lymphatic System in Rats
Ichihashi, T., Kinoshita, H., Takagishi, Y., & Yamada, H. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb05464.x · Cited by 34
Renou, C., Carrière, F., Ville, E., Grandval, P., Joubert-Collin, M., & Laugier, R. (2001) · Digestion · doi:10.1159/000051891 · Cited by 30 · cited 1×
“Although gastric lipolysis is a minor contributor to the overall lipid digestion process, it has been suggested to be responsible for up to 25% of acyl chain hydrolysi”
BackgroundBehrens, D., Fricker, R., Bodoky, A., Drewe, J., Harder, F. H., & Heberer, M. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9503791 · Cited by 30 · cited 1×
“These data suggest that in certain circumstances the use of medium-chain lipids in lipid-based formulations (even in the presence of surfactant) can lead to drug precipitation, and therefore reduced absorption, as a result of luminal digestion of the formulation lipi”
Background(2006) · Wiley eBooks · doi:10.1002/0470097981 · Cited by 30
Ring, A., Pohl, J., Völkl, A., & Stremmel, W. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200285-jlr200 · Cited by 29
Intestinal absorption of retinol and retinyl palmitate in the rat. Effects of tetrahydrolipstatin
Fernández, E., & Borgström, B. (1990) · Lipids · doi:10.1007/bf02537163 · Cited by 29
Nishimukai, M., & Hara, H. (2004) · Journal of Nutrition · doi:10.1093/jn/134.8.1862 · Cited by 29
FUKUI, E., KUROHARA, H., KAGEYU, A., KUROSAKI, Y., NAKAYAMA, T., & KIMURA, T. (1989) · Journal of Pharmacobio-Dynamics · doi:10.1248/bpb1978.12.80 · Cited by 27
Takada, K., Yoshimura, H., Yoshikawa, H., Muranishi, S., Yasumura, T., & Oka, T. (1986) · Pharmaceutical Research · doi:10.1023/a:1016324932378 · Cited by 26
Intestinal-fatty acid binding protein and lipid transport in human intestinal epithelial cells
Montoudis, A., DELVIN, E. E., Ménard, D., Beaulieu, J., Jean, D., Tremblay, É., Bendayan, M., & Levy, E. H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.202 · Cited by 26 · cited 1×
“and/or act as cytosolic storage 'sinks' for excess, and potentially toxic, quantities of free fatty-acid and exogenous substance”
BackgroundWasan, K. M., Ramaswamy, M., McIntosh, M. P., Porter, C. J. H., & Charman, W. N. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980353k · Cited by 26
Self-citationChronic Collection of Mesenteric Lymph From Conscious, Tethered Rats.
Hauss, D. J., Fogal, S. E., & FICORILLI, J. V. (1998) · PubMed · Cited by 26
Konishi, T., Satsu, H., Hatsugai, Y., Aizawa, K., Inakuma, T., Nagata, S., Sakuda, S., Nagasawa, H., & Shimizu, M. (2004) · BioFactors · doi:10.1002/biof.5520220113 · Cited by 25 · cited 1×
“have shown increased accumulation of a P-gp drug substrate in Caco-2 cells on incubation of the cells with monoglycerid”
BackgroundSchoeller, C., Keelan, M., Mulvey, G. L., Stremmel, W., & Thomson, A. B. R. (1995) · PubMed · Cited by 25
Intestinal Lymph Lipoproteins in Rats Fed Diets Enriched in Specific Fatty Acids
FELDMAN, E. B., Russell, B. S., Hawkins, C. B., & Forte, T. M. (1983) · Journal of Nutrition · doi:10.1093/jn/113.11.2323 · Cited by 24
Influence of dietary fat saturation on lipid absorption in the rat
Sheehe, D. M., Green, J. B., & Green, M. H. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90016-7 · Cited by 24 · cited 1×
“In general, monounsaturated and polyunsaturated fatty acids also promote lymphatic lipid transport more readily and produce larger lipoproteins when compared with saturated fatty acid”
BackgroundRautureau, M., Bisalli, A., & Jc, R. (1981) · PubMed · Cited by 23
Effect of Bile on Absorption of Mepitiostane by the Lymphatic System in Rats
Ichihashi, T., KINOSHITA, H., Takagishi, Y., & Yamada, H. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb05465.x · Cited by 22
Triglyceride biosynthesis in the intestinal mucosa
Johnston, J. M., & Rao, G. A. (1965) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(65)90089-5 · Cited by 20 · cited 1×
“Exogenous monoglyceride and fatty acid are primarily re-synthesized to triglyceride by the monoglyceride pathway, which consists of a group of enzymes (triglyceride synthetase) present on the surface of the smooth ER (SER”
BackgroundLymphatic uptake of MK-386, a sterol 5α-reductase inhibitor, from aqueous and lipid formulations
Kwei, G. Y., Novak, L. B., Hettrick, L. H., Reiss, E. R., Fong, E. K. F., Olah, T. V., & Loper, A. E. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00392-x · Cited by 19
The assembly of hepatic very low density lipoproteins: Evidence of a role for the Golgi apparatus
Valyi‐Nagy, K., Harris, C. M., & Swift, L. L. (2002) · Lipids · doi:10.1007/s11745-002-0974-3 · Cited by 19
Sterol carrier protein‐2:Not just for cholesterol any more
Murphy, E. J. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1020580706912 · Cited by 18
Ohtani, N., Sasaki, I., Naito, H., Shibata, C., & Matsuno, S. (2001) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(01)80065-2 · Cited by 17
Karpf, D. M., Holm, R., Garafalo, C., Levy, E. H., Jacobsen, J. B., & Müllertz, A. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20431 · Cited by 17 · cited 1×
“Recently, Caco-2 cells have also been used to examine the influence of lipids and lipid-formulation excipients on drug incorporation into lipoproteins and the initial data are encouragin”
Intestinal triacylglycerol storage pool size changes under differing physiological conditions
Nevin, P., Koelsch, D., & Mansbach, C. M. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39721-2 · Cited by 17
Role of the intestine in chylomicron remnant clearance
Mansbach, C. M., & Dowell, R. F. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.269.1.g144 · Cited by 16
Surgical techniques for long-term studies of thoracic duct circulation in the rat
Girardet, R. (1975) · Journal of Applied Physiology · doi:10.1152/jappl.1975.39.4.682 · Cited by 15
Surgical techniques for long-term study of thoracic duct lymph circulation in dogs
Girardet, R. E., & Benninghoff, D. L. (1973) · Journal of Surgical Research · doi:10.1016/0022-4804(73)90073-5 · Cited by 14 · cited 1×
“Consequently, various animal models have been developed to estimate the likely intestinal lymphatic drug transport in human”
BackgroundIsolation and characterization of a mucosal triacylglycerol pool undergoing hydrolysis
Tipton, A. D., Frase, S., & Mansbach, C. M. (1989) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1989.257.6.g871 · Cited by 12
ApoE: Crossroads between Alzheimer's Disease and Atherosclerosis
Stojaković, T., Scharnagl, H., & März, W. (2004) · Seminars in Vascular Medicine · doi:10.1055/s-2004-861496 · Cited by 12
Trevaskis, N. L., Lo, C. M., Li, Y., Tso, P., Irving, H. R., Porter, C. J. H., & Charman, W. N. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9021-6 · Cited by 9 · cited 1×
“At the very least, however, cytosolic lipid-binding proteins are likely to alter the intracellular disposition of lipophilic drugs indirectly through their effect on intestinal lipid absorption and pooling within the enterocyt”
BackgroundSelf-citationSukhotnik, I., May, N., Görk, S., Chen, M., Drongowski, R. A., Coran, A. G., & Harmon, C. M. (2002) · Pediatric Surgery International · doi:10.1007/s00383-002-0861-9 · Cited by 8
Factors Determining the Intrinsic Lymphatic Partition Rate of Epitiostanol and Mepitiostane
Ichihashi, T., Takagishi, Y., & Yamada, H. (1992) · Pharmaceutical Research · doi:10.1023/a:1015824710957 · Cited by 7
Cited by
McClements, D. J., & Rao, J. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.559558 · Cited by 1,630
“Lipid digestion also depends on the molecular characteristics of digestible triacylglycerols oils, eg, medium-chain triglycerides (MCT) tend to be digested more rapidly than long-chain triglycerides (corn oil) ( Porter et al, 2007 ).”
BackgroundStrategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
“Lymphatic drug transport has been described for many highly lipophilic drugs and has been the subject of several reviews (Porter and Charman, 2001b; O’Driscoll, 2002; Porter et al., 2007; Trevaskis et al., 2008; Yanez et al., 2011).”
BackgroundMethodInfluentialSelf-citationNanoemulsion: Concepts, development and applications in drug delivery
Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.008 · Cited by 1,358
“Drugs which enter mesenteric lymph are directly transported to systemic circulation without undergoing hepatic first pass metabolism[92].”
BackgroundBiomedical Applications of Supramolecular Systems Based on Host–Guest Interactions
Ma, X., & Zhao, Y. (2015) · Chemical Reviews · doi:10.1021/cr500392w · Cited by 1,225
McClements, D. J., & Li, Y. (2010) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2010.06.010 · Cited by 905
Metadata
- Authors
- Porter, C. J. H., Trevaskis, N. L., & Charman, W. N.
- Affiliations
- Monash University (AU)
- Corresponding author
- Porter, Christopher J. H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-03
- Volume
- 6
- Issue
- 3
- Pages
- 231-248
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2069235788
- Cited by
- 1,824
- References
- 253
- Citations by year
- 2026: 88 · 2025: 87 · 2024: 67 · 2023: 89 · 2022: 119 · 2021: 108 · 2020: 140 · 2019: 101 · 2018: 117 · 2017: 121 · 2016: 125 · 2015: 119 · 2014: 120 · 2013: 128 · 2012: 94
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- lipid-based drug delivery, oral bioavailability, lipophilic drugs, poorly water-soluble drugs, lipid excipients, first-pass metabolism, lipid-based formulations
- MeSH terms
- Administration, Oral, Animals, Pharmaceutical Preparations, Excipients, Humans, Intestinal Absorption, Lipids, Drug Design, Drug Delivery Systems, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.